Potential Effectiveness of the Diabetes Prevention Program in the Peri-urban Area of Bamako, Mali
PPD-Mali
2 other identifiers
interventional
440
1 country
6
Brief Summary
The proposed research is an innovative adaptation of the Centers for Disease Control and Prevention's (CDC) Diabetes Prevention Program "Power to Prevent" program, which will be developed and piloted in the low-income peri-urban neighborhoods of Bamako, Mali. This program is well-suited to delivery by the city's community health workers already supporting families in improving maternal and child health outcomes. First, it will use participatory research methods to engage them and community residents in making adaptations to the community health worker's guidelines and tools for recommended activities so that they are linguistically and culturally appropriate, including guidelines for food consumption using locally available foods. These adaptations will use more graphics and photographs, so they are appropriate for low-literacy participants. Second, another key innovation is the explicit orientation to couples, where only one may have a diagnosed cardiovascular disease. This adaptation will provide tools the women can use in negotiating for changes to the family's meals and her daily routine. Third, investigators will conduct a comparative effectiveness study at 6 community health centers with high rates of Cardiovascular Disease (CVD), recruiting adults recently diagnosed with diabetes or hypertension. Based on the random allocation of their community health center, participants will be assigned to one of three groups of 150 each: Couples, with at least one meeting the eligibility criteria; Individuals, men and women, both eligible; Comparison, men and women with CVD. Trained community health workers and diabetic peer educators will use the adapted Diabetes Prevention Program (DPP) materials with the Couples and Individuals groups over a period of 6 months. At the conclusion of this pilot investigators will assess the levels of adoption of recommended cardiovascular risk reduction behaviors and changes in obesity, hypertension, and diabetes control, comparing differences in outcomes between the three groups. It will enable Mali to incorporate diabetes and hypertension risk reduction into their already deployed networks of community health workers. The Malian DPP adaptation will also be suitable for Francophone West Africa, where customs and lifestyles are similar among the millions of families confronting the burdens of cardiovascular disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes-mellitus-type-2
Started Nov 2021
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 26, 2021
CompletedFirst Submitted
Initial submission to the registry
December 6, 2021
CompletedFirst Posted
Study publicly available on registry
March 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedDecember 27, 2023
December 1, 2023
7 months
December 6, 2021
December 20, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Adoption of the recommended diet and exercise behavior
Number of participant who adopt the DPP recommended diet and exercise behavior
Month 0 to Month 6
Secondary Outcomes (3)
Reduction in Body Mass Index (BMI)
Month 0 to Month 6
Reduction in number of participants with Hypertension
Month 0 to Month 6
Reduction in number of participants with hyperglycemia
Month 0 to Month 6
Study Arms (3)
Individuals
EXPERIMENTALThis arm is composed of diabetic or hypertensive men and women who participate without joint participation of their spouse. The intervention consists of exposing participants to bi-monthly educational sessions on diet and exercise. Participants will be organized in groups of 15 led by one community health worker (CHW) assisted by a diabetes peer educator (PE). The basic format for the group sessions will follow the pattern developed with the DPP program, beginning with a discussion of "success" stories from the past weeks before proceeding to the didactic portion of the session. The sessions will mix the didactic portions facilitated by the PE with group discussions, activities and role plays, facilitated by the CHW.
Couples
EXPERIMENTALWomen recruited for the couples group will be asked to invite their husbands to participate, regardless of their husband's CVD status, and men whose wives do not have CVD similarly will be asked to enroll with their wife. The intervention consists in exposing them to bi-monthly educational sessions on diet and exercise. The intervention consists in exposing participants with bi-monthly educational sessions on diet and exercise. Participants will be organized in groups of 15 to 30, led by one community health worker (CHW) assisted by a diabetes peer educator (PE). The basic format for the group sessions will follow the pattern developed with the DPP program, beginning with a discussion of "success" stories from the past weeks before proceeding to the didactic portion of the session. The sessions will mix the didactic portions facilitated by the PE with group discussions, activities and role plays, facilitated by the CHW.
Comparison
NO INTERVENTIONThe comparison group is composed of diabetic or hypertensive individuals who agreed to participate in the study but who will not be exposed to the sessions.
Interventions
Adaptation of the Centers for Disease Control and Prevention (CDC) Diabetes Prevention Program Power to Prevent for use in low income neighborhoods in Bamako, Mali
Eligibility Criteria
You may qualify if:
- Aged 25 or more
- Diagnosed with type II diabetes or hypertension or Obesity
- Willing to commit to participate at biweekly sessions for 6 months
You may not qualify if:
- History of stroke or cardiac arrest
- Gestational diabetes
- Type I diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
ASACOBA
Bamako, Mali
Asacodjeneka
Bamako, Mali
ASACODOU
Bamako, Mali
Asacola B5
Bamako, Mali
Asacola Ii
Bamako, Mali
Asacosisou
Bamako, Mali
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Seydou Doumbia, MD, PhD
USTTB
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 6, 2021
First Posted
March 2, 2022
Study Start
November 26, 2021
Primary Completion
June 28, 2022
Study Completion
April 30, 2023
Last Updated
December 27, 2023
Record last verified: 2023-12